Key result
Patients attaining a maximum rate pressure product > 25000 during an inconclusive exercise stress test had significantly fewer cardiovascular events and required no abnormal downstream testing at 2 years.
Why the study?
Does achieving a maximum rate pressure product > 25000 predict the absence of cardiovascular events and abnormal downstream testing in patients with inconclusive exercise stress tests due to poor functional capacity?
Observational (n=236)
No
Does achieving a maximum rate pressure product > 25000 predict the absence of cardiovascular events and abnormal downstream testing in patients with inconclusive exercise stress tests due to poor functional capacity?
Achieving a maximum rate pressure product > 25000 during an otherwise negative but functionally limited exercise stress test identifies patients at very low risk for CV events at 2 years, potentially obviating the need for further downstream testing.
Answers are grounded in this paper and cite their sources.
MRPP may refine testing decisions after inconclusive EST; leaves open superiority over APMHR for CV outcomes.
BACKGROUND: Exercise stress testing (EST) in patients with poor functional capacity measured by time on treadmill is typically deemed inconclusive and usually leads to further downstream testing. The aim of this study was firstly to evaluate the maximum rate pressure product (MRPP) during initial EST to assessthe need for follow-up testing; and secondly to investigate if MRPP is better than age predicted maximum heart rate (APMHR) for diagnostic outcome based on follow up cardiovascular (CV) events in patients with inconclusive EST due to poor functional capacity. METHODS: From a total of 2761 tests performed, 236 tests were considered inconclusive due to poor functional capacity which were available for analysis. From receiver operating characteristic (ROC) analysis, a cut-off value for MRPP of 25000 was chosen using CV events as the outcome measure (sensitivity 97%, specificity 45%). Cases were then categorised into those with an MRPP > 25000 and < 25000. RESULTS: Regardless of treadmill time, any patient attaining an MRPP > 25000 had no abnormal downstream testing or CV events at 2 years follow-up. On ROC analysis MRPP outperformed APMHR for sensitivity and specificity (area under curve 0.76 vs. 0.59, respectively). CONCLUSIONS: The results suggest that regardless of functional capacity, individuals whose EST is terminated at maximal fatigue, with no electrocardiogram evidence or symptoms of myocardial ischemia and yields an MRPP > 25000, do not require further downstream testing. Furthermore, this group of patients, while not immune to future CV events, have significantly better outcomes than those not attaining a MRPP > 25000.
No takes yet. Share an insight, caveat, or question.
Whitman et al. (2018) conducted an observational in Suspected coronary artery disease (n=236). Maximum rate pressure product > 25000 vs. Maximum rate pressure product < 25000 was evaluated on Cardiovascular events (AUC 0.76, p=<0.05). Patients attaining a maximum rate pressure product > 25000 during an inconclusive exercise stress test had significantly fewer cardiovascular events and required no abnormal downstream testing at 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: